Validación de una nueva escala para predecir qué pacientes con fibrilación auricular y fracción de eyección reducida responderán a la ablación con catéter

Serban, Teodor; Lavallaz, Jeanne du Fay du; Barker, David Charles; Sticherling, Christian; Kühne, Michael; Badertscher, Patrick

doi:10.1016/j.recesp.2023.03.020

Revista Española de Cardiología

2023

DOI: 10.1016/j.recesp.2023.03.020

|View full text |Cite

Validación de una nueva escala para predecir qué pacientes con fibrilación auricular y fracción de eyección reducida responderán a la ablación con catéter

Teodor Serban

Jeanne du Fay du Lavallaz

David Charles Barker

et al.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2024

Publication Types

Select...

Article2

Relationship

Self Cite1

Independent1

Authors

Journals

Cited by 2 publications

References 5 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

Biomarkers to predict improvement of left ventricular ejection fraction after atrial fibrillation ablation

Serban,

Hennings,

Strebel

et al. 2024

Heart Rhythm

View full text Add to dashboard Cite

Biomarkers to predict improvement of left ventricular ejection fraction after atrial fibrillation ablation

Serban,

Hennings,

Strebel

et al. 2024

Heart Rhythm

View full text Add to dashboard Cite

Definition and management of arrhythmia-induced cardiomyopathy: findings from the European Heart Rhythm Association survey

Serban,

Badertscher,

du Fay de Lavallaz

et al. 2024

Europace

Self Cite

View full text Add to dashboard Cite

Background Arrhythmia-induced Cardiomyopathy (AiCM) represents a subtype of acute heart failure (HF) in the context of sustained arrhythmia. Clear definitions and management recommendations for AiCM are lacking. Purpose The European Heart Rhythm Association Scientific Initiatives Committee (EHRA SIC) conducted a survey to explore the current definitions and management of patients with AiCM among European and non-European electrophysiologists. Methods A 25-item online questionnaire was developed and distributed among EP specialists on the EHRA SIC website and on social media between September 4th and October 5th 2023. Results Of the 206 respondents, 16% were female and 61% were between 30-49 years old. Most of the respondents were EP-Specialists (81%) working at University Hospitals (47%). While most participants (67%) agreed that AiCM should be defined as a left ventricular ejection fraction (LVEF) impairment after new onset of an arrhythmia, only 35% identified a specific LVEF drop to diagnose AiCM with a wide range of values (5-20% LVEF drop). Most respondents considered all available therapies: catheter ablation(93%), electrical cardioversion(83%), antiarrhythmic drugs (76%) and adjuvant HF treatment(76%). 83% of respondents indicated that adjuvant HF treatment should be started at first HF diagnosis prior to antiarrhythmic treatment and 84% agreed it should be stopped within six months after LVEF normalization. Responses for the optimal time point for the first LVEF reassessment during follow-up varied markedly (1 day-6 months after antiarrhythmic treatment). Conclusion This EHRA Survey reveals varying practices regarding AiCM among physicians, highlighting a lack of consensus and heterogenous care of these patients.

show abstract

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

customersupport@researchsolutions.com

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

Validación de una nueva escala para predecir qué pacientes con fibrilación auricular y fracción de eyección reducida responderán a la ablación con catéter

Cited by 2 publications

References 5 publications

Biomarkers to predict improvement of left ventricular ejection fraction after atrial fibrillation ablation

Biomarkers to predict improvement of left ventricular ejection fraction after atrial fibrillation ablation

Definition and management of arrhythmia-induced cardiomyopathy: findings from the European Heart Rhythm Association survey

Contact Info

Product

Resources

About